Close Menu

NEW YORK (360Dx) – Meso Scale Diagnostic today announced it received its first clearance from the US Food and Drug Administration for an in vitro diagnostic.

The agency cleared Meso Scale's conventional C-reactive protein assay, which is based on the company's Multi-Array technology. The technology has been used in life science research applications for about 20 years. CRP is a diagnostic biomarker that has taken on importance for its applications in personalized medicine and companion diagnostics, Meso Scale said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.